Science Explorer Interactive view Map
Company · Shanghai · China

Bayer (China)

bayer.com.cn/?l=en-usROR OpenAlex
Research works
66
▲ 7% vs 2013–17
Citations
811
12.4 per fractional work
Top-10% rate
24.1%
record average 16.5%
Open access
40%
world 28%

Not ranked overall: Bayer (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.19× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.36× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.67× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 4.70× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.68× its world share, 0 worksChemistryComputer Science: 0.03× its world share, 0 worksComputer ScienceEngineering: 0.14× its world share, 0 worksEngineeringMaterials Science: 0.26× its world share, 0 worksMaterials ScienceMathematics: 2.54× its world share, 0 worksMathematicsPhysics and Astronomy: 0.46× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.13× its world share, 0 worksHealth ProfessionsMedicine: 3.67× its world share, 12 worksMedicineNursing: 8.80× its world share, 1 worksNursingBusiness, Management and Accounting: 0.12× its world share, 0 worksBusiness, Management…Decision Sciences: 0.41× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.23× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 8.8×. Every wedge is a field page.

Which keywords describe research at Bayer (China)?

By fractional works in all years, weighted toward what it does more of than the world: Risk Factors, Diagnosis, Clinical Practice Guidelines, Treatment, Prophylaxis, Antithrombotic Therapy, Guidelines and Pulmonary Embolism.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Risk Factors5▲ 7.9×9 topics
  2. Treatment5▲ 5.8×16 topics
  3. Diagnosis5▲ 7.0×11 topics
  4. Clinical Practice Guidelines4▲ 12×8 topics
  5. Epidemiology4▲ 1.50×30 topics
  6. Inflammation4▲ 2.3×21 topics
  7. Prophylaxis3▲ 36×2 topics
  8. Antithrombotic Therapy3▲ 46×2 topics
  9. Cardiovascular Disease3▲ 4.2×15 topics
  10. Guidelines3▲ 8.9×5 topics
  11. Pulmonary Embolism3▲ 63×1 topic
  12. Venous Thromboembolism3▲ 63×1 topic
  13. Global Burden2▲ 6.4×5 topics
  14. Biological Control2▲ 16×3 topics
  15. Catalysis2▲ 3.3×5 topics
  16. Precision Medicine2▲ 9.0×4 topics
  17. Prevention Guidelines2▲ 28×3 topics
  18. Stroke Prevention2▲ 22×2 topics
  19. Anticoagulant Therapy2▲ 22×1 topic
  20. Atrial Fibrillation2▲ 27×1 topic
  21. Catheter Ablation2▲ 21×2 topics
  22. Heart Failure2▲ 5.8×6 topics
  23. Ischemic Stroke2▲ 19×1 topic
  24. Neuroprotection2▲ 7.0×2 topics
  25. Thrombolysis2▲ 46×1 topic
  26. Magnetic Resonance Imaging2▲ 6.5×5 topics
  27. Clinical Guidelines1▲ 6.9×4 topics
  28. Medicinal Chemistry1▲ 5.6×4 topics
  29. Myocardial Infarction1▲ 8.0×2 topics
  30. Coronary Artery Disease1▲ 16×3 topics
  31. Cardiovascular Events1▲ 12×3 topics
  32. Circular Economy1▲ 9.4×2 topics
  33. Cost-effectiveness Analysis1▲ 25×1 topic
  34. Environmental Risk Assessment1▲ 18×2 topics
  35. Health Utility Measures1▲ 25×1 topic
  36. Medical Imaging1▲ 6.9×2 topics
  37. Quantitative Analysis1▲ 11×1 topic
  38. Radiomics1▲ 28×1 topic
  39. Biotechnology1▲ 17×1 topic
  40. Genetically Modified Crops1▲ 134×1 topic

Which research topics does Bayer (China) publish most on?

By volume in 2022–2025: Radiomics and Machine Learning in Medical Imaging, Cardiac Imaging and Diagnostics, MRI in cancer diagnosis and Hepatocellular Carcinoma Treatment and Prognosis.

Radiomics and Machine Le…1Radiomics and Machine Learning in Medical Imaging: 1 fractional worksCardiac Imaging and Diagnostics: 1 fractional worksMRI in cancer diagnosis0MRI in cancer diagnosis: 0 fractional worksHepatocellular Carcinoma Treatment and Prognosis: 0 fractional worksCardiovascular Disease and Adiposity: 0 fractional worksLung Cancer Diagnosis and Treatment: 0 fractional worksCardiovascular Function …0Cardiovascular Function and Risk Factors: 0 fractional worksHormonal Regulation and Hypertension: 0 fractional worksHemophilia Treatment and Research: 0 fractional worksProstate Cancer Treatment and Research: 0 fractional works
Radiology, Nuclear Medicine and ImagingHepatologyCardiology and Cardiovascular MedicinePulmonary and Respiratory Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Cardiac Imaging and Diagnostics Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 MRI in cancer diagnosis Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
  5. 5 Cardiovascular Disease and Adiposity Cardiology and Cardiovascular Medicine 0 works
  6. 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  7. 7 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 0 works
  8. 8 Hormonal Regulation and Hypertension Endocrinology, Diabetes and Metabolism 0 works
  9. 9 Hemophilia Treatment and Research Hematology 0 works
  10. 10 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.6%not open60.4%

World: 28% of research is openly available.

with international co-authors44.7%domestic only55.3%

World: 19% is written across borders.

How has Bayer (China)'s research output changed?

Output in 2018–2022 was 7% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Shanghai

All research institutions in Shanghai

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.